(Note: For PDF File Swipe To The End Of Article)
Introduction to Tuberculosis
Tuberculosis, commonly known as TB, is an infectious disease caused primarily by Mycobacterium tuberculosis. It most commonly affects the lungs, where it is called pulmonary tuberculosis, but it can involve almost any organ of the body. Tuberculosis remains an important global health problem because it can spread from person to person, cause severe illness, and become life-threatening when untreated.
Mycobacterium tuberculosis is a slow-growing, acid-fast bacillus with a lipid-rich cell wall that contributes to its ability to survive within host cells and resist certain environmental conditions. The organism is transmitted mainly through the air when a person with infectious pulmonary or laryngeal tuberculosis releases tiny airborne particles while coughing, speaking, singing, or sneezing.
Not everyone who becomes infected with M. tuberculosis develops active tuberculosis. Following inhalation, the immune system may contain the bacteria within granulomatous lesions, producing what is commonly called latent tuberculosis infection. In other individuals, the bacteria multiply and cause active disease. Reactivation can also occur years after the initial infection if immune control becomes weakened.
Tuberculosis can produce a wide range of clinical manifestations. Pulmonary disease may cause persistent cough, sputum production, fever, night sweats, weight loss, fatigue, and sometimes hemoptysis. Extrapulmonary tuberculosis can produce symptoms related to the affected organ, including lymph nodes, pleura, brain, bones, kidneys, abdomen, or reproductive organs.
Early diagnosis and appropriate treatment are essential. Untreated active tuberculosis can progressively damage affected organs and can spread to other people. Modern multidrug therapy can cure most drug-susceptible cases when the appropriate medications are taken correctly for the recommended duration.
Understanding the Difference Between Tuberculosis Infection and Tuberculosis Disease
Tuberculosis infection and active tuberculosis disease are not identical conditions.
A person with tuberculosis infection may carry M. tuberculosis in the body without having symptoms or being capable of transmitting the infection under ordinary circumstances. The immune system has contained the bacteria, preventing them from producing active disease.
Active tuberculosis disease occurs when the bacteria multiply sufficiently to cause clinical illness and tissue damage. Pulmonary or laryngeal tuberculosis can be infectious and may transmit bacteria through the air.
This distinction is important because a person with latent tuberculosis infection can appear completely healthy. They may have no cough, fever, weight loss, or abnormal chest findings. However, some people with untreated infection can later develop active tuberculosis, particularly when immune defenses become weakened.
The evaluation of a person with suspected tuberculosis therefore involves determining whether there is tuberculosis infection, active disease, or another condition producing similar symptoms.
The Causative Organism
Tuberculosis is caused mainly by Mycobacterium tuberculosis, a member of the Mycobacterium tuberculosis complex.
The organism has several characteristics that are important in understanding the disease. It is an aerobic, non-spore-forming, non-motile, acid-fast bacillus. Its cell wall contains a high concentration of complex lipids, including mycolic acids.
The lipid-rich cell wall contributes to the organism's resistance to decolorization by acid-alcohol during laboratory staining. This characteristic gives rise to the term acid-fast bacillus, or AFB.
The bacterium grows slowly compared with many other common bacterial pathogens. Its slow growth contributes to the prolonged nature of tuberculosis and has historically made laboratory diagnosis and culture more time-consuming.
M. tuberculosis has an important ability to survive within macrophages. After inhalation into the lungs, the organisms may be engulfed by alveolar macrophages. Instead of being rapidly destroyed, however, the bacteria can persist within these cells and interact with the host immune response.
Transmission of Tuberculosis
Tuberculosis is primarily transmitted through the airborne route.
When a person with infectious pulmonary or laryngeal tuberculosis coughs, sneezes, speaks, sings, or performs activities that generate respiratory aerosols, tiny particles containing M. tuberculosis can be released into the surrounding air.
These particles may remain suspended in poorly ventilated indoor environments. Another person can inhale them and allow the organisms to reach the respiratory tract.
Transmission is influenced by several factors, including:
- Infectiousness of the source patient
- Bacterial burden
- Frequency and force of coughing
- Duration of exposure
- Ventilation
- Crowding
- Duration of contact
- Use of effective treatment
Tuberculosis is not usually spread through casual contact such as shaking hands or sharing ordinary objects. The major concern is prolonged exposure to contaminated airborne particles from an infectious person.
Pathophysiology of Tuberculosis
The pathogenesis of tuberculosis begins when infectious aerosol particles containing M. tuberculosis are inhaled.
Small particles can travel deep into the respiratory tract and reach the alveoli. There, the bacteria encounter alveolar macrophages and other components of the innate immune system.
Macrophages engulf the organisms, but M. tuberculosis has mechanisms that allow it to survive and replicate within host cells.
As the infection develops, the immune system activates a cell-mediated response. T lymphocytes and macrophages play central roles in attempting to contain the infection.
Activated macrophages accumulate around infected areas, while lymphocytes coordinate the immune response. The resulting organized collection of immune cells is known as a granuloma.
Granuloma formation is an important defense mechanism because it helps contain the bacteria. However, the granuloma can also undergo tissue necrosis, producing the characteristic caseous appearance associated with tuberculosis.
In some patients, the immune system successfully contains the infection. In others, bacteria continue multiplying and cause progressive tissue destruction.
Tuberculosis may also spread through lymphatic channels and the bloodstream. Hematogenous dissemination can produce miliary tuberculosis, in which numerous small lesions develop in multiple organs.
Primary Tuberculosis
Primary tuberculosis refers to infection occurring in a person who has not previously developed protective immunity to M. tuberculosis.
After inhalation, bacteria typically establish infection in the lower parts of the upper lobes or upper portions of the lower lobes of the lungs.
The initial pulmonary lesion together with involvement of draining lymph nodes may form what is known as the primary complex.
In many immunocompetent individuals, the immune system contains the infection. The lesions may heal and become fibrotic or calcified.
However, viable organisms may remain dormant within the body. These organisms can later reactivate if immune control becomes inadequate.
Latent Tuberculosis Infection
Latent tuberculosis infection occurs when a person has been infected with M. tuberculosis but does not have active tuberculosis disease.
People with latent infection generally:
- Have no symptoms
- Do not have active tissue destruction
- Usually do not transmit tuberculosis
- May have evidence of immune sensitization to M. tuberculosis
- May develop active disease later
The risk of progression from infection to active disease varies according to individual circumstances.
Conditions that weaken immune function can substantially increase the risk of reactivation.
Reactivation Tuberculosis
Reactivation tuberculosis occurs when previously contained M. tuberculosis becomes active again.
It frequently affects the upper regions of the lungs because of factors such as oxygen availability and local tissue conditions.
Reactivation disease may produce cavitary lesions in the lungs. Cavitation can result in a high bacterial burden and may increase infectiousness.
Reactivation can occur years after the initial infection.
Factors that increase the risk include:
- HIV infection
- Immunosuppressive medications
- Certain cancers
- Diabetes mellitus
- Chronic kidney disease
- Malnutrition
- Advanced age
- Other conditions associated with impaired immunity
Causes and Risk Factors for Tuberculosis
The fundamental cause of tuberculosis is infection with M. tuberculosis. However, the likelihood of developing active disease depends strongly on host factors and environmental circumstances.
Important risk factors include:
- Close contact with a person with infectious TB
- Living in crowded conditions
- Poor ventilation
- HIV infection
- Diabetes mellitus
- Immunosuppressive therapy
- Malnutrition
- Certain cancers
- Chronic kidney disease
- Silicosis
- Previous untreated tuberculosis infection
Healthcare workers and people living or working in settings where tuberculosis transmission is more likely may also have increased exposure risk.
Pulmonary Tuberculosis
Pulmonary tuberculosis is the most common form of tuberculosis disease.
The lungs are the primary site of infection because the organism is usually acquired through inhalation.
Pulmonary tuberculosis may develop gradually, with symptoms progressing over weeks or months rather than appearing suddenly.
Common symptoms include:
- Persistent cough
- Sputum production
- Fever
- Night sweats
- Weight loss
- Loss of appetite
- Fatigue
- Chest discomfort
- Hemoptysis
- Shortness of breath in advanced disease
The severity of symptoms varies according to the extent of pulmonary involvement.
Clinical Manifestations of Tuberculosis
Tuberculosis can present with constitutional symptoms as well as organ-specific manifestations.
Common constitutional symptoms include:
- Fever
- Night sweats
- Fatigue
- Weakness
- Loss of appetite
- Unintentional weight loss
Pulmonary symptoms include persistent cough, sputum production, chest pain, and hemoptysis.
Extrapulmonary tuberculosis produces manifestations related to the affected organ. For example, tuberculosis meningitis may cause headache and altered consciousness, while tuberculous lymphadenitis may cause persistent lymph node enlargement.
Because tuberculosis can mimic many other diseases, persistent unexplained symptoms require appropriate clinical evaluation.
Cough in Pulmonary Tuberculosis
A persistent cough is one of the most important symptoms of pulmonary tuberculosis.
The cough may initially be dry but can later become productive as airway inflammation and pulmonary lesions progress.
Sputum may contain blood when tuberculosis causes damage to pulmonary blood vessels or erodes into airways.
A persistent cough should not automatically be assumed to be tuberculosis because many respiratory disorders can cause chronic cough. However, tuberculosis should be considered when chronic cough occurs together with systemic symptoms or relevant exposure and epidemiological risk factors.
Hemoptysis in Tuberculosis
Hemoptysis refers to coughing up blood originating from the respiratory tract.
Tuberculosis can cause hemoptysis through erosion of blood vessels within infected lung tissue or cavities.
The amount of bleeding can vary from small blood-streaked sputum to severe pulmonary hemorrhage.
Significant or recurrent hemoptysis requires urgent medical evaluation because it can compromise the airway and may indicate extensive pulmonary disease.
Fever and Night Sweats
Fever is a common systemic manifestation of tuberculosis.
It may be persistent or intermittent and is often accompanied by fatigue and reduced appetite.
Night sweats are another classic constitutional symptom. Some patients experience significant sweating that requires changing clothing or bedding.
However, fever and night sweats are nonspecific and may occur in many infectious, inflammatory, and malignant conditions.
Weight Loss and Loss of Appetite
Unintentional weight loss is common in active tuberculosis.
Chronic infection can increase metabolic demands while simultaneously reducing appetite. Inflammatory mediators can also contribute to changes in metabolism and energy balance.
Progressive weight loss may become particularly pronounced in advanced disease.
Nutritional assessment is therefore an important component of tuberculosis management.
Extrapulmonary Tuberculosis
Tuberculosis can spread beyond the lungs and affect almost any organ.
Important forms of extrapulmonary tuberculosis include:
- Tuberculous lymphadenitis
- Tuberculous meningitis
- Pleural tuberculosis
- Tuberculosis of bones and joints
- Abdominal tuberculosis
- Genitourinary tuberculosis
- Pericardial tuberculosis
- Miliary tuberculosis
- Tuberculosis of the spine
Extrapulmonary disease can be difficult to diagnose because symptoms may be nonspecific and the affected organ may not initially suggest tuberculosis.
Tuberculous Lymphadenitis
Tuberculous lymphadenitis is a common form of extrapulmonary tuberculosis.
It often involves cervical lymph nodes and may present as slowly enlarging, usually painless lymph node swelling.
The nodes may become matted together and can eventually develop necrosis or sinus formation.
Diagnosis may involve imaging, fine-needle aspiration, biopsy, microbiological testing, and molecular testing.
Tuberculous Meningitis
Tuberculous meningitis is one of the most serious forms of extrapulmonary tuberculosis.
It occurs when M. tuberculosis reaches the meninges and produces inflammation around the brain and spinal cord.
Symptoms may develop gradually and include:
- Persistent headache
- Fever
- Vomiting
- Altered consciousness
- Neck stiffness
- Cranial nerve abnormalities
- Behavioral changes
- Seizures
Tuberculous meningitis can cause serious neurological complications, including hydrocephalus, cerebral infarction, cranial nerve dysfunction, and permanent neurological disability.
Early diagnosis and treatment are essential.
Tuberculosis of Bones and Joints
Tuberculosis can involve bones and joints, particularly the spine.
Spinal tuberculosis is often referred to as Pott disease.
Patients may develop:
- Persistent back pain
- Spinal tenderness
- Reduced mobility
- Vertebral destruction
- Spinal deformity
- Neurological deficits in severe disease
Spinal tuberculosis can produce compression of neural structures and may result in weakness or paralysis.
Diagnosis commonly requires imaging and microbiological or histological confirmation when feasible.
Abdominal Tuberculosis
Abdominal tuberculosis can involve the intestines, peritoneum, lymph nodes, or other abdominal structures.
Symptoms may include:
- Abdominal pain
- Fever
- Weight loss
- Diarrhea
- Constipation
- Abdominal distension
- Loss of appetite
- Vomiting
The disease can sometimes resemble inflammatory bowel disease, malignancy, or other abdominal infections.
Imaging, endoscopy, biopsy, and microbiological testing may be required for diagnosis.
Pleural Tuberculosis
Tuberculosis can involve the pleural space and cause a tuberculous pleural effusion.
Patients may develop:
- Fever
- Chest pain
- Shortness of breath
- Dry cough
Pleural fluid analysis can provide useful diagnostic information. Depending on the clinical situation, additional testing such as pleural biopsy may be required.
Pericardial Tuberculosis
Tuberculosis can involve the pericardium and produce tuberculous pericarditis.
Inflammation may cause pericardial effusion. Severe fluid accumulation can impair cardiac filling and lead to cardiac tamponade.
Symptoms may include:
- Fever
- Chest discomfort
- Shortness of breath
- Fatigue
- Swelling in severe cases
Pericardial tuberculosis requires specialized medical management because complications can be life-threatening.
Miliary Tuberculosis
Miliary tuberculosis occurs when M. tuberculosis disseminates through the bloodstream and produces numerous small lesions throughout the body.
The term "miliary" refers to the characteristic appearance of tiny lesions resembling millet seeds.
Miliary tuberculosis may involve:
- Lungs
- Liver
- Spleen
- Bone marrow
- Kidneys
- Brain
- Adrenal glands
- Other organs
Patients may present with fever, weight loss, weakness, respiratory symptoms, or dysfunction of affected organs.
Miliary disease can be life-threatening and requires urgent treatment.
Diagnosis of Tuberculosis
The diagnosis of tuberculosis requires integration of clinical findings, microbiological testing, imaging, and sometimes histopathology.
Important diagnostic methods include:
- Sputum examination
- Molecular testing
- Mycobacterial culture
- Chest radiography
- CT imaging when indicated
- Biopsy
- Tuberculin skin testing
- Interferon-gamma release assays
The appropriate combination of investigations depends on whether active pulmonary tuberculosis, extrapulmonary tuberculosis, or latent infection is suspected.
Sputum Examination
Sputum examination is particularly important in suspected pulmonary tuberculosis.
A respiratory specimen can be tested for acid-fast bacilli using microscopy. However, microscopy has limitations and may not detect all cases.
Microbiological confirmation is particularly valuable because it can establish the presence of M. tuberculosis and, through additional testing, provide information about drug susceptibility.
Molecular Testing
Rapid molecular tests have transformed tuberculosis diagnosis.
Nucleic acid amplification methods can detect M. tuberculosis genetic material and, depending on the assay, provide information about resistance to important medications.
Molecular testing can produce results much faster than traditional culture.
This is particularly valuable when rapid diagnosis is necessary to initiate appropriate treatment and infection-control measures.
Mycobacterial Culture
Culture remains an important reference method for confirming tuberculosis and determining drug susceptibility.
Because M. tuberculosis grows slowly, culture results may take substantially longer than molecular tests.
Culture nevertheless remains extremely valuable, particularly when drug resistance is suspected or when molecular results require confirmation.
Chest X-Ray Findings
Chest radiography is an important imaging investigation in suspected pulmonary tuberculosis.
Possible findings include:
- Upper-lobe infiltrates
- Cavitary lesions
- Fibrotic changes
- Hilar lymphadenopathy
- Pleural effusion
- Nodular lesions
- Miliary patterns
Radiographic findings vary depending on the stage of disease, patient's age, immune status, and whether infection is primary or reactivation disease.
A chest X-ray can support the diagnosis but cannot independently prove tuberculosis.
Computed Tomography
CT scanning provides greater anatomical detail than standard chest radiography.
It may help identify:
- Cavitation
- Small nodules
- Lymphadenopathy
- Pleural disease
- Airway abnormalities
- Complications
CT is particularly useful when chest radiography is inconclusive or when detailed assessment of disease extent is necessary.
Tuberculin Skin Test
The tuberculin skin test, also known as the Mantoux test, assesses immune sensitization to tuberculosis antigens.
A small amount of tuberculin is injected into the skin, and the resulting induration is measured after the appropriate interval.
The interpretation depends on the size of induration and the individual's risk factors.
A positive test indicates immune sensitization but does not by itself distinguish latent tuberculosis infection from active tuberculosis disease.
Interferon-Gamma Release Assays
Interferon-gamma release assays, or IGRAs, are blood tests that measure immune responses to specific M. tuberculosis antigens.
They are useful for detecting tuberculosis infection, particularly in situations where testing for latent infection is required.
Like the tuberculin skin test, an IGRA cannot by itself establish active tuberculosis disease.
Differential Diagnosis of Tuberculosis
Tuberculosis can resemble numerous other diseases.
Possible differential diagnoses include:
- Bacterial pneumonia
- Lung cancer
- Fungal infections
- Sarcoidosis
- Lung abscess
- Bronchiectasis
- Atypical mycobacterial infection
- Lymphoma
- Inflammatory bowel disease in abdominal presentations
The differential diagnosis depends on the organ involved and the clinical presentation.
Microbiological and histopathological confirmation is particularly important when treatment decisions carry significant consequences.
Treatment of Drug-Susceptible Tuberculosis
Treatment of active drug-susceptible tuberculosis requires multiple antibiotics because M. tuberculosis can develop resistance when a single medication is used alone.
A standard initial regimen commonly includes:
- Isoniazid
- Rifampicin
- Pyrazinamide
- Ethambutol
The initial intensive phase is followed by a continuation phase using fewer drugs according to the specific treatment regimen.
Treatment duration depends on the site of disease, drug susceptibility, clinical circumstances, and applicable guidelines.
The exact regimen should be prescribed and monitored by an appropriately qualified healthcare professional.
Why Multiple Drugs Are Used
Tuberculosis treatment requires combination therapy for several reasons.
First, tuberculosis populations can contain organisms with naturally occurring resistance to individual drugs. Using multiple medications reduces the probability that resistant organisms will survive and multiply.
Second, different drugs act against bacteria through different mechanisms.
Third, combination therapy improves the likelihood of eliminating organisms from different biological environments within the body.
Using inadequate therapy or stopping treatment prematurely can allow resistant organisms to survive and contribute to drug-resistant tuberculosis.
Isoniazid
Isoniazid is an important antituberculous medication that interferes with the synthesis of mycolic acids, which are important components of the mycobacterial cell wall.
It is highly effective against susceptible M. tuberculosis and forms part of many standard treatment regimens.
A clinically important adverse effect is hepatotoxicity. Isoniazid can also cause peripheral neuropathy, particularly in susceptible individuals.
Pyridoxine supplementation may be recommended for individuals at increased risk of isoniazid-associated neuropathy.
Rifampicin
Rifampicin is a powerful antituberculous medication that inhibits bacterial RNA synthesis by targeting bacterial DNA-dependent RNA polymerase.
It is a cornerstone of treatment for drug-susceptible tuberculosis.
Rifampicin has numerous drug interactions because it induces hepatic enzymes and transport systems that can accelerate metabolism of various medications.
It can also cause orange-red discoloration of body fluids such as urine and tears, which is generally harmless but should be explained to patients before treatment begins.
Pyrazinamide
Pyrazinamide is particularly useful during the initial phase of tuberculosis treatment.
It has activity against certain populations of M. tuberculosis in acidic environments.
Important adverse effects include hepatotoxicity and increased uric acid levels, which may contribute to gout-like symptoms in susceptible individuals.
Ethambutol
Ethambutol inhibits mycobacterial cell wall-related processes and is included in many initial tuberculosis regimens.
One of its most important adverse effects is optic toxicity.
Patients receiving ethambutol may require appropriate assessment of visual function, especially when treatment continues for an extended period.
Patients should report new visual changes promptly.
Drug-Resistant Tuberculosis
Drug-resistant tuberculosis occurs when M. tuberculosis develops resistance to one or more antituberculous medications.
Resistance can arise through genetic mutations and can be selected or amplified when treatment is inadequate.
Important categories include:
- Rifampicin-resistant tuberculosis
- Multidrug-resistant tuberculosis
- More extensively drug-resistant forms
Drug-resistant tuberculosis is more difficult to treat and may require specialized regimens using second-line or newer antituberculous medications.
Rapid drug-resistance testing is therefore extremely important when resistance is suspected.
Factors Contributing to Drug Resistance
Drug resistance can emerge or spread because of several factors.
These may include:
- Inadequate treatment regimens
- Incorrect medication combinations
- Interrupted therapy
- Poor adherence
- Drug interactions
- Inadequate drug absorption
- Transmission of resistant organisms
Ensuring accurate diagnosis, appropriate treatment, adequate drug supply, adherence support, and monitoring is essential for controlling drug-resistant tuberculosis.
Adherence to Tuberculosis Treatment
Tuberculosis treatment often lasts for many months, which can make adherence challenging.
Patients may begin feeling better before all bacteria have been eliminated. This improvement can create the mistaken impression that treatment is no longer necessary.
Stopping medication prematurely can result in treatment failure, relapse, ongoing transmission, and development of drug resistance.
Healthcare systems may therefore use adherence-support strategies, patient education, counseling, and supervised treatment approaches when appropriate.
Adverse Effects of Tuberculosis Treatment
Antituberculous medications can cause adverse effects, and patients should be monitored appropriately.
Potential problems include:
- Hepatotoxicity
- Gastrointestinal symptoms
- Peripheral neuropathy
- Visual disturbances
- Increased uric acid
- Drug interactions
- Allergic reactions
Patients should report symptoms such as severe nausea, persistent vomiting, abdominal pain, jaundice, dark urine, significant visual changes, severe rash, or other concerning reactions promptly.
Tuberculosis and the Liver
Several antituberculous medications can affect liver function.
Isoniazid, rifampicin, and pyrazinamide are particularly important in relation to hepatotoxicity.
Patients with pre-existing liver disease may require additional monitoring and individualized treatment decisions.
Symptoms suggesting significant liver injury include:
- Jaundice
- Dark urine
- Persistent nausea
- Vomiting
- Severe abdominal discomfort
- Marked fatigue
- Loss of appetite
Tuberculosis and HIV
HIV infection is one of the most important risk factors for progression from tuberculosis infection to active disease.
HIV weakens cell-mediated immunity, reducing the body's ability to contain M. tuberculosis.
People living with HIV may develop tuberculosis at unusual sites and may have atypical radiological findings.
Tuberculosis is also an important cause of illness among people with advanced HIV infection.
Management requires coordinated treatment of both conditions, including careful attention to drug interactions and the timing of antiretroviral therapy.
Tuberculosis in Children
Tuberculosis in children may present differently from tuberculosis in adults.
Children may develop:
- Fever
- Poor weight gain
- Failure to thrive
- Persistent cough
- Reduced activity
- Lymph node enlargement
Young children and those with weakened immune systems may be at greater risk of severe forms such as tuberculosis meningitis or disseminated tuberculosis.
Diagnosis can be challenging because children may have difficulty producing sputum and may have lower bacterial loads.
Tuberculosis in Pregnancy
Tuberculosis can occur during pregnancy and requires appropriate medical evaluation and treatment.
Untreated active tuberculosis can have serious consequences for the mother and pregnancy.
Treatment decisions during pregnancy should be individualized, taking into account the disease site, drug susceptibility, maternal condition, and safety considerations for the fetus.
Pregnant patients should not discontinue prescribed tuberculosis treatment without medical advice.
Complications of Tuberculosis
Untreated tuberculosis can cause serious complications.
Possible complications include:
- Massive hemoptysis
- Respiratory failure
- Pulmonary fibrosis
- Bronchiectasis
- Pneumothorax
- Pleural disease
- Tuberculosis meningitis
- Hydrocephalus
- Stroke associated with meningitis
- Spinal cord compression
- Bone destruction
- Kidney damage
- Infertility in some forms of genitourinary disease
- Miliary dissemination
- Death
The nature of the complications depends on the organs involved and the severity of disease.
Tuberculosis and Respiratory Failure
Extensive pulmonary tuberculosis can significantly impair gas exchange.
Large areas of inflammation, consolidation, cavitation, fibrosis, and airway damage can reduce effective lung function.
Severe disease may result in hypoxemia and respiratory failure, particularly in patients with extensive bilateral pulmonary involvement or disseminated disease.
Such patients require urgent hospital-based management.
Tuberculosis and Bronchiectasis
Chronic pulmonary tuberculosis can permanently damage the airways.
Destruction and distortion of bronchial structures may result in bronchiectasis.
Patients with post-tuberculous bronchiectasis may experience chronic cough, sputum production, recurrent respiratory infections, and hemoptysis even after the original tuberculosis has been successfully treated.
Tuberculosis Prevention
Prevention requires reducing transmission, identifying cases early, treating infectious patients effectively, and preventing progression from tuberculosis infection to active disease.
Important strategies include:
- Early diagnosis
- Effective treatment
- Appropriate infection-control measures
- Adequate ventilation
- Respiratory hygiene
- Contact investigation
- Testing of people at increased risk
- Treatment of eligible latent infections
- Vaccination programs where recommended
Public health programs play an important role because tuberculosis is both an individual medical problem and a community health concern.
BCG Vaccination
The Bacillus Calmette-Guérin vaccine, commonly known as BCG, is used in many countries as part of tuberculosis prevention programs.
BCG provides its strongest protection against certain severe forms of childhood tuberculosis, particularly tuberculosis meningitis and disseminated disease.
Its effectiveness against adult pulmonary tuberculosis varies between populations.
BCG vaccination policies differ according to country and local tuberculosis epidemiology.
Infection Control in Tuberculosis
Infectious pulmonary tuberculosis requires appropriate infection-control precautions.
Important measures include:
- Early identification of suspected cases
- Appropriate respiratory precautions
- Adequate ventilation
- Appropriate respiratory protection for healthcare workers
- Prompt initiation of effective therapy
- Evaluation of relevant contacts
Patients with potentially infectious tuberculosis may need to follow specific instructions regarding masking, isolation, and avoiding close contact until healthcare professionals determine that the risk of transmission has been adequately reduced.
Contact Investigation
When a person is diagnosed with infectious tuberculosis, people who have had significant exposure may require evaluation.
Contacts may be assessed using:
- Medical history
- Symptom assessment
- Tuberculosis infection testing
- Chest imaging when indicated
- Additional investigations for suspected disease
Children and people with weakened immune systems may require particularly prompt evaluation because they can be at increased risk of progression to severe disease.
Latent Tuberculosis Treatment
People with latent tuberculosis infection may be offered preventive treatment when they meet appropriate criteria.
The objective is to eliminate dormant bacteria before they can reactivate and cause active disease.
The choice and duration of preventive therapy depend on factors such as age, risk of progression, drug interactions, previous treatment, and local guidelines.
Before starting preventive treatment, active tuberculosis should be appropriately excluded.
Tuberculosis and Nutrition
Malnutrition can increase susceptibility to tuberculosis and may worsen outcomes in patients with active disease.
Tuberculosis itself can contribute to weight loss and nutritional deficiencies.
Nutritional assessment and appropriate dietary support can therefore be important components of comprehensive care.
Patients with significant weight loss may require individualized nutritional counseling and monitoring.
Tuberculosis and Social Stigma
Tuberculosis can carry significant social stigma.
Some individuals may fear discrimination because of misconceptions about how tuberculosis spreads. Patients may also feel embarrassed, isolated, or reluctant to seek medical attention.
Education is essential for reducing stigma.
Tuberculosis is an infectious medical condition, not a reflection of a person's character, cleanliness, or moral behavior. Supportive communication can encourage patients to seek diagnosis, complete treatment, and cooperate with public health measures.
Prognosis of Tuberculosis
The prognosis of tuberculosis depends on the site and severity of disease, immune status, drug susceptibility, timing of diagnosis, and adherence to appropriate treatment.
Drug-susceptible tuberculosis is generally treatable and curable when an appropriate regimen is completed.
Delayed diagnosis can allow disease to progress and can increase the risk of complications and transmission.
Drug-resistant tuberculosis generally requires more complex treatment and may have a less favorable prognosis.
Early recognition, accurate microbiological diagnosis, appropriate therapy, and adherence are therefore fundamental to successful outcomes.
The Importance of Early Diagnosis and Treatment
Tuberculosis often develops gradually, which can make early recognition difficult. Persistent cough, unexplained fever, night sweats, weight loss, or other compatible symptoms should prompt appropriate medical evaluation, particularly in individuals with relevant exposure or risk factors.
Early diagnosis benefits both the individual patient and the wider community. Effective treatment can prevent progression of disease, reduce complications, and eventually eliminate infectiousness.
Laboratory confirmation and drug-susceptibility assessment are especially important because treatment must be tailored appropriately when resistance is present.
Tuberculosis remains a major infectious disease, but it is preventable and treatable. Comprehensive care requires attention not only to antimicrobial therapy but also to nutrition, adherence, infection control, contact evaluation, underlying conditions, and long-term follow-up.
.jpeg)
